
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
China’s space start-ups eye IPO boom as SpaceX heads for record listing
-
China’s BYD claims Germany’s plug-in hybrid crown, disrupting market of iconic auto giants
-
Hacking of Philippine Senate’s website spotlights widening political crisis
-
Fury over Jared Kushner’s Albania resort project threatens to engulf political elite
-
China leads US in everyday AI apps but firms are overvalued, experts say

Singapore Clamps Down on Foreign Interference Involving South Asians
The Dark Side of Asia’s ‘Miracle Diet’
Thailand Seeks to Revive Its Peninsular White Elephant